Bronchopulmonary dysplasia;Dysplasie bronchopulmonaire

Revue des Maladies Respiratoires

Volumn 13, Issue 3, 1996, Pages 243-249

  Clement A ^a  

^a ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

bronchopulmonary dysplasia; exogenous surfactant; neonatal respiratory distress syndrome; prematurity

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; SURFACTANT;

ARTIFICIAL VENTILATION; HUMAN; LUNG DEVELOPMENT; LUNG DYSPLASIA; OXYGEN THERAPY; PREMATURITY; RESPIRATORY DISTRESS SYNDROME; REVIEW;

ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BRONCHOPULMONARY DYSPLASIA; FETAL ORGAN MATURITY; GESTATIONAL AGE; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; LUNG; OXYGEN INHALATION THERAPY; PULMONARY SURFACTANTS; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 0029974980     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. NORTHWAY W, ROSAN R, PORTER D: Pulmonary disease following respiratory therapy in hyaline membrane disease: bronchopulmonary dysplasia. N Engl J Dis 1967;276:357-68.
2. NORTHWAY W: Bronchopulmonary dysplasia: then and now. Arch Dis Child 1990;65:1076-81.
3. HORBAR J, WRIGHT L, SOLL R, WRIGHT E, FANAROFF A, KORONES S et al.: A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. J Pediatr 1993;123:757-66.
4. TRUOG W, JACKSON C, BADURA R: Bronchopulmonary dysplasia and pulmonary insufficiency of prematurity. Am J Dis Child 1985;139:351-4.
5. ZUPAN V, LEYRONNAS D, DEHAN M: Dysplasie bronchopulmonaire. Rev Mal Respir 1991;8:351-65.
6. GREENOUGH A: Bronchopulmonary dysplasia: early diagnosis, prophylaxis and treatment. Arch Dis Child 1990;65:1082-8.
7. FITZGERALD P, DONOGHUE V, GORMAN W: Bronchopulmonary dysplasia: a radiographic and clinical review of 20 patients. Br J Radiol 1990;63:444-7.
8. FINKELSTEIN J, HOROWITZ S, SINKIN R, RYAN R: Cellular and molecular responses to injury in relation to induction of tissue repair and fibrosis. Clin Perinatol 1992;19:603-20.
9. ERICKSON A, DE LA MONTE S, MOORE G, HUTCHINS G: The progression of morphologic changes in bronchopulmonary dysplasia. Am J Pathol 1987;127:474-84.
10. MARGRAF M, TOMASHEFSKI J, BRUCE M, DAHMS B: Morphometric analysis of the lung in bronchopulmonary dysplasia. Am Rev Respir Dis 1991;143:391-400.
11. FARRELL P, PALTA M: Bronchopulmonary dysplasia. In: Farrell PM, Taussig LM, eds. Bronchopulmonary dysplasia and isolated chronic respiratory disorders. Columbus; Ohio: Ross Laboratories, 1986:1-7.
12. HANSEN T, WALLACH M, DEY A, BOIVIN P, VOHR B, OH W: Pronostic value of clinical and radiological status on day 28 of life for subsequent course in very low birthweight (<1,500g) babies with bronchopulmonary dysplasia. Pediatr Pulmonol 1993;15:327-31.
13. BRODY J, THURLBECK W: Development, growth and aging of the lung. In: Macklem PT, Mead J eds. Handbook of physiology, section 3: the respiratory system. Bethesda: American Physiologic Society, 1986:355-86.
14. LANGSTON C, KIDSA K, REED M, THURLBECK M: Human lung growth in late gestation and in the neonate. Am Rev Respir Dis 1984;129:607-13.
15. ZELTNER T, BURRI P: The postnatal development and growth of the human lung. I. Morphometry. Respir Physiol 1987;67:247-67.
16. ZELTNER T, BURRI P: The postnatal development and growth of the human lung. II. Morphology. Respir Physiol 1987;67:269-82.
17. THURLBECK W: Prematurity and the developing lung. Clin Perinatol 1992;19:497-519.
18. DAVIS J, DICKERSON B, METLAY L: Differential effects of oxygen and barotrauma on lung injury in the neonatal piglet. Pediatr Pulmonol 1991;10:157-63.
19. PHILIP A: Oxygen plus pressure plus time: the etiology of bronchopulmonary dysplasia. Pediatrics 1975;55:44-50.
20. CRAPO J: Morphologic changes in pulmonary oxygen toxicity. Am Rev Physiol 1986;45:721-31.
21. NASH G, BLENNERHASSETT J, PONTOPPIDAN H: Pulmonary lesions associated with oxygen therapy and artificial ventilation. N Engl J Med 1967;276:368-74.
22. SAUGSTAD O: Oxygen toxicity in the neonatal period. Acta Paediatr Scand 1990;79:881-92.
23. BHUTANI V, ABBASI S: Long-term pulmonary sequences in survivors with bronchopulmonary dysplasia. Clin Perinatol 1992;19:649-71.
24. MCMOY K, BAGWELL C, WAGNER M, SALLENT J, O'KEEFE M, KOSCH P: Spirometric and endoscopic evaluation of airway collapse in infants with bronchopulmonary dysplasia. Pediatr Pulmonol 1992;14:23-7.
25. SOUTHALL D, SAMUELS M: Bronchopulmonary dysplasia: a new look at management. Arch Dis Child 1990;65:1089-95.
26. MORIETTE G, GAUDEBOUT C, CLEMENT A, BOULE M, BION B, RELIER J, GAULTIER C: Pulmonary function at 1 year of age in survivors of neonatal respiratory distress. Pediatr Pulmonol 1987;3;242-50.
27. BLAYNEY M, KEREM E, WHYTE H, O'BRODOVICH H: Bronchopulmonary dysplasia: improvement in lung function between 7 and 10 years of age. J Pediatr 1991;118:201-6.
28. YEH T, MCCLENAN D, AJAYI O, PILDES R: Metabolic rate and energy balance in infants with bronchopulmonary dysplasia. J Pediatr 1989;114:448-51.
29. VOHR B, BELL E: Infants with bronchopulmonary dysplasia: growth pattern and neurologic and developmental outcome. Am J Dis Child 1987;136:443-7.
30. BREGMAN J, FARRELL E: Neurodevelopmental outcome in infants with bronchopulmonary dysplasia. Clin Perinatol 1992;19:673-94.
31. BANCALARI E, SOSENKO I: Pathogenesis and prevention of neonatal chronic lung disease: recent developments. Pediatr Pulmonol 1990;8:109-16.
32. DAVIS J, SINKIN R, ARANDA J: Drug therapy for bronchopulmonary dysplasia. Pediatr Pulmonol 1990;65:117-25.
33. RUSH M, HAZINSKI T: Current therapy of bronchopulmonary dysplasia. Clin Perinatol 1992;19:563-87.
34. BENSON B: Genetically engineered human pulmonary surfactant. Clin Perinatol 1993;20:791-811.
35. CORSET A: Clinical trials of synthetic surfactant in the respiratory distress syndrome of premature infants. Clin Perinatol 1993;20:737-60.
36. HUDAK B, EGAN E: Impact of lung surfactant therapy on chronic lung diseases in premature infants. Clin Perinatol 1992;19:591-603.
37. MERCIER C, SOLL R: Clinical trials of natural surfactant extract in respiratory distress syndrome. Clin Perinatol 1993;20:711-35.
38. CLOUTIER M: Nebulized steroid therapy in bronchopulmonary dysplasia. Pediatr Pulmonol 1993;15:111-6.
39. NG P: The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia. Arch Dis Child 1993;68:330-6.
40. TRUOG W, JACKSON L: Alternative modes of ventilation in the prevention and treatment of bronchopulmonary dysplasia. Clin Perinatol 1992;19:621-47.
41. FRANK L: Antioxidants, nutrition, and bronchopulmonary dysplasia. Clin Perinatol 1992;19:541-61.
42. COALSON J, WINTER V, GERSTMANN D, IDELL S, KING R, DELEMOS R: Pathophysiologic, morphometric, and biochemical studies of the premature baboon with bronchopulmonary dysplasia. Am Rev Respir Dis 1992;145:872-81.